Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (39)	5/26/1998 7:22:00 PM
From: B.REVERE	Respond to of 1722

[briefing.com]--today 13:55--PFIZER INC. (PFE) 103 7/8 -1 9/16. Pharmaceutical stock continues to sink on fears over its Viagra drug after it was reported last week that the impotence drug could be linked to six deaths. While both the FDA and Pfizer continue to look into the cause of the deaths, which occurred during clinical trials of 4,500 men, the FDA continues to back the drug as safe and effective for its labeled indication and intended use. However, investors have taken a slightly more negative view, although given the rapid rise in the stock associated with this wonder drug, some profit taking was probably in store and this latest scare is only being used as an excuse to take profits. With more than one million prescriptions for Viagra already issued, there is likely to be little sales drop-off once the dust settles and it is shown that Viagra by itself did not contribute to the deaths reported last week. Still, it seems that investors will need to be convinced that Viagra will continue to receive the backing of the FDA and that its safety profile will not be significantly altered. With sales likely to exceed the $1 billion mark in its first year, and exceed $3.5 billion in four years or less, Viagra is likely to be a significant growth engine that drives and supports the high multiple that PFE currently enjoys, even after the recent price correction.

To: Anthony Wong who wrote (39)	5/26/1998 7:53:00 PM
From: david bell	Read Replies (1) \| Respond to of 1722

As a urologist one of the more common etiologies for impotence that I see in the office is vascular in origin reflecting systemic vascular disease whether clinical or not. In many patients the development of impotence may be viewed as being cardioprotective as the are unable to exert themselves with intercourse. With viagra they are now running marathons!! Heart is not used to it ending in the ultimate orgasm! I think you will hear more and more of these deaths although I do not think it is fully PFE resposibility/